𝛼SK or Search

ENTITY

China Biologic Products (CBPO US)

28

Analysis

Health Care • United States

China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.

more

Refresh

Exchange Announcement • 13 May 2023 00:20

US SEC Form SC 13D/A for China Biologic Products Holdings Inc

Exchange Announcement • 30 Apr 2021 14:13

US SEC Form 15-12B for China Biologic Products Holdings Inc

Exchange Announcement • 23 Apr 2021 00:23

US SEC Form SC 13D/A for China Biologic Products Holdings Inc

Exchange Announcement • 22 Apr 2021 17:15

US SEC Form SC 13D/A for China Biologic Products Holdings Inc

Exchange Announcement • 22 Apr 2021 17:10

US SEC Form SC 13D/A for China Biologic Products Holdings Inc

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x